PT-2023-26043 · Assembly · Trialworks

Charles Heidbreder · Publicado 2023-07-24 · Atualizado 2023-07-31 · CVE-2023-37613

Positive Technologies (AI Summary)

CVSS v3.1

6.1

Média

Vetor base

AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Name of the Vulnerable Software and Affected Versions Assembly Software Trialworks version 11.4

Description A cross-site scripting (XSS) issue allows attackers to execute arbitrary web scripts or HTML by injecting a crafted payload into the asset src parameter. This enables the execution of malicious code on the client-side.

Recommendations For Assembly Software Trialworks version 11.4, consider restricting access to the asset src parameter to minimize the risk of exploitation until a patch is available. Avoid using the asset src parameter in sensitive operations until the issue is resolved. At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Exploit

XSS

Enumeração de Fraquezas

CWE-79

Identificadores relacionados

CVE-2023-37613

Produtos afetados

Trialworks

Referências · 5

• 🔥 https://github.com/HeidiSecurities/CVEs/blob/main/Trialworks.md · Exploit
• 🔥 https://github.com/HeidiSecurities/CVEs/blob/main/CVE-2023-37613/Trialworks.md · Exploit
• https://nvd.nist.gov/vuln/detail/CVE-2023-37613 · Nota de Segurança
• https://t.me/cibsecurity/67181 · Publicação no Telegram
• https://osv.dev/vulnerability/CVE-2023-37613 · Aviso do Fabricante